Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer [Corrigendum]
Chang J, Hong L, Liu Y. Cancer Manag Res. 2020;12:2641–2651. The authors have advised that there is an error in Figure 2E on page 2646. The authors apologize for this error. Read the original article
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-05-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/corrigendum-targeting-pik3cg-in-combination-with-paclitaxel-as-a-poten-peer-reviewed-article-CMAR |
| Summary: | Chang J, Hong L, Liu Y. Cancer Manag Res. 2020;12:2641–2651.
The authors have advised that there is an error in Figure 2E on page 2646.
The authors apologize for this error.
Read the original article |
|---|---|
| ISSN: | 1179-1322 |